About IO Biotech

We are a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on our T-win technology platform.

Our product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

We aim to disrupt the way cancer is treated with our approach, solidifying our product candidates as the cornerstones for multiple solid tumors.

Leadership

We have assembled a seasoned management team with extensive experience in developing novel oncology therapies, including advancing product candidates from preclinical research through to clinical development, and ultimately to regulatory approval.

Mai-Britt Zocca, Ph.D.

Mai-Britt Zocca, Ph.D.

Founder, Chief Executive Officer

Keith Vendola, MD MBA

Keith Vendola, MD MBA

Chief Financial Officer

Eva Ehrnrooth, M.D., Ph.D.

Eva Ehrnrooth, M.D., Ph.D.

Chief Medical Officer

Muhammad Al-Hajj, Ph.D.

Muhammad Al-Hajj, Ph.D.

Chief Scientific Officer

Mikkel Dybkjaer, MSc

Mikkel Dybkjaer, MSc

VP Corporate Finance

Andrew Willis

Andrew Willis

SVP, Regulatory, CMC & Quality

Ayako Wakatsuki Pedersen, Ph. D.

Ayako Wakatsuki Pedersen, Ph. D.

VP, Translational Research

Board of Directors

Our board of directors has deep expertise in the fields of immuno-oncology, business and finance.

Peter Hirth, Ph.D.

Peter Hirth, Ph.D.

Chairman

Kathleen Sereda Glaub, M.B.A.

Kathleen Sereda Glaub, M.B.A.

Member

Christian Elling, Ph.D.

Christian Elling, Ph.D.

Member – Lundbeckfonden

Emmanuelle Coutanceau, Ph.D.

Emmanuelle Coutanceau, Ph.D.

Member – Novo Holdings

Claus Andersson, Ph.D.

Claus Andersson, Ph.D.

Member - Sunstone Life Science Ventures

Priyanka Belawat, Ph.D.

Priyanka Belawat, Ph.D.

Member – HBM Healthcare Investments

Jack B. Nielsen, M. Sc.

Jack B. Nielsen, M. Sc.

Member - Vivo Capital

Vanessa Malier

Vanessa Malier

Member – Kurma Partners

Scientific Advisory Board

Kapil Dhingra, MD, Ph.D.

Kapil Dhingra, MD, Ph.D.

Strategic R&D Advisor

Professor Mads Hald Andersen, MD, Ph.D.

Professor Mads Hald Andersen, MD, Ph.D.

Founder, Scientific Advisor

Professor, MD, Ph.D. Inge Marie Svane

Professor, MD, Ph.D. Inge Marie Svane

Founder, Clinical Advisor

Alexander Eggermont, MD, PhD, Professor

Alexander Eggermont, MD, PhD, Professor

Clinical advisor